pan-KRAS-IN-8
Product Specifications
UNSPSC Description
pan-KRAS-IN-8 (Compound 38) is an inhibitor for in human tumor mutated genes KRAS, which inhibits proliferation of KRAS mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC50 of 0.07 and 0.18 nM, respectively[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pan-kras-in-8.html
Solubility
10 mM in DMSO
Smiles
OC[C@H]1N(CC#CC2=C[C@]([C@]3=C(CC(C)(C)COC4=O)C5=CC(C6=CSC(C[C@H](NC([C@H]7[C@H](C)[C@@H]7C)=O)C(N8CCC[C@@H]4N8)=O)=N6)=CC=C5N3CC)=C([C@H](C)OC)N=C2)CCOC1
Molecular Weight
880.11
References & Citations
[1]Chen YF, et al., Pan-kras inhibitor compound. WO2024060966A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162441/pan-KRAS-IN-8-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162441/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1435516 Inquire
Recombinant Nanoarchaeum equitans Glutamate--tRNA ligase (gltX), partial
Ask
View Details 
36690141 1x10<sup>6</sup> cells/1.0ml
PIK3R6 CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details